Alyeska Investment Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Alyeska Investment Group’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-249,301	Closed	-$24.2M	–	533
2019 Q3	$24.2M	Sell	249,301 -268	-0.1%	-$26.8K	0.35%	100
2019 Q2	$25.6M	Buy	249,569 +19,169	+8%	+$2.07M	0.33%	100
2019 Q1	$26.2M	Buy	+230,400	New	+$16.9M	0.35%	93
2017 Q4	–	Sell	-151,621	Closed	-$13.5M	–	570
2017 Q3	$13.5M	Buy	+151,621	New	+$11.5M	0.1%	218
2016 Q4	–	Sell	-3,954	Closed	-$237K	–	589
2016 Q3	$237K	Buy	+3,954	New	+$228K	﹤0.01%	439
2015 Q3	–	Sell	-45,979	Closed	-$2.77M	–	562
2015 Q2	$2.77M	Buy	45,979 +3,361	+8%	+$222K	0.03%	322
2015 Q1	$3.3M	Buy	+42,618	New	+$2.45M	0.05%	317

Alyeska Investment Group's ONCE Position: Q4 2019 in Review

Alyeska Investment Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 249,301 shares — an estimated $24.2M sold.

Alyeska Investment Group first reported a position in ONCE in Q1 2015 and held it in 7 quarters. The position peaked at $26.2M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Alyeska Investment Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Alyeska Investment Group sold 249,301 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $24.2M.
Alyeska Investment Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 7 quarters.
Alyeska Investment Group's Spark Therapeutics, Inc. Common Stock position peaked at $26.2M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Alyeska Investment Group's 13F filing for Q4 2019, filed 14 Feb 2020.